Medirom Healthcare Technologies Inc (MRM) — Cash Flow Reinvestment Rate

Latest as of March 2024: 2.86x

Medirom Healthcare Technologies Inc (MRM) has a Cash Flow Reinvestment Rate of 2.86x as of March 2024, reinvesting $79.60 Million (capex $79.60 Million ) from operating cash flow of $27.79 Million. See MRM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.86x
(Capex + Investments) / Operating CF

Total Reinvested

$79.60 Million
Capex + Investments

Operating Cash Flow

$27.79 Million
USD

Capital Expenditures

$79.60 Million
USD

Medirom Healthcare Technologies Inc Cash Flow Reinvestment Rate (2018–2019)

Historical reinvestment intensity for Medirom Healthcare Technologies Inc across 2 annual periods. For the full cash flow conversion analysis, see Medirom Healthcare Technologies Inc (MRM) cash flow conversion.

Annual Cash Flow Reinvestment Rate for Medirom Healthcare Technologies Inc (2018–2019)

Year-by-year capital reinvestment analysis for Medirom Healthcare Technologies Inc. See financial flexibility index of Medirom Healthcare Technologies Inc to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 6.72x $52.85 Million $7.87 Million $7.41 Million ▲ +738.0%
2018 0.80x $113.69 Million $141.87 Million $34.30 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow